Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Net Income: 2010-2024

Historic Net Income for CorMedix (CRMD) over the last 15 years, with Dec 2024 value amounting to -$17.9 million.

  • CorMedix's Net Income rose 4002.28% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year increase of 496.27%. This contributed to the annual value of -$17.9 million for FY2024, which is 62.52% up from last year.
  • Per CorMedix's latest filing, its Net Income stood at -$17.9 million for FY2024, which was up 62.52% from -$47.8 million recorded in FY2023.
  • In the past 5 years, CorMedix's Net Income ranged from a high of -$17.9 million in FY2024 and a low of -$47.8 million during FY2023.
  • Moreover, its 3-year median value for Net Income was -$29.7 million (2022), whereas its average is -$31.8 million.
  • As far as peak fluctuations go, CorMedix's Net Income slumped by 61.07% in 2023, and later spiked by 62.52% in 2024.
  • Yearly analysis of 5 years shows CorMedix's Net Income stood at -$22.0 million in 2020, then fell by 28.07% to -$28.2 million in 2021, then declined by 5.29% to -$29.7 million in 2022, then plummeted by 61.07% to -$47.8 million in 2023, then soared by 62.52% to -$17.9 million in 2024.